市場調査レポート
商品コード
1464576

経カテーテル僧帽弁留置術(TMVI)市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業)、2024年最新版

Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日: | 発行: GlobalData | ページ情報: 英文 92 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
経カテーテル僧帽弁留置術(TMVI)市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業)、2024年最新版
出版日: 2024年03月29日
発行: GlobalData
ページ情報: 英文 92 Pages
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経カテーテル心臓弁は、天然組織(主に牛または牛由来の生物学的材料)で構成された人工心臓弁で、ステント(鋼またはコバルトクロム製)として知られる柔軟なメッシュフレームで囲まれており、すべてがカテーテルとして知られる細長いチューブに設置されています。カテーテルは鼠径部の太い血管(経大腿部)または胸部の小さな切開創(経胸壁)から挿入されます。心臓内に挿入された僧帽弁は、バルーンを膨らませることによって自然な位置に開き、患者の病変のある僧帽弁内に留置されます。

当レポートでは、経カテーテル僧帽弁留置術(TMVI)市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

  • 経カテーテル僧帽弁留置術(TMVI)の概要

第3章 開発中の製品

  • 経カテーテル僧帽弁留置術(TMVI) - 開発段階別パイプライン製品
  • 経カテーテル僧帽弁留置術(TMVI) - 地域別パイプライン製品
  • 経カテーテル僧帽弁留置術(TMVI) - 規制経路別パイプライン製品
  • 経カテーテル僧帽弁留置術(TMVI) - 推定承認日別パイプライン製品
  • 経カテーテル僧帽弁留置術(TMVI) - 進行中の臨床試験

第4章 経カテーテル僧帽弁留置術(TMVI)- 各社開発中のパイプライン製品

  • 経カテーテル僧帽弁留置術(TMVI)企業- 開発段階別のパイプライン製品
  • 経カテーテル僧帽弁留置術(TMVI)- 開発段階別のパイプライン製品

第5章 経カテーテル僧帽弁留置術(TMVI)の企業と製品の概要

  • 4C Medical Technologies Inc
  • Abbott Vascular Inc
  • Annulon
  • Cardiovalve Ltd
  • Cephea Valve Technologies, Inc.
  • Colibri Heart Valve LLC
  • Direct Flow Medical Inc
  • Edwards Lifesciences Corp
  • Emory University
  • Foldax Inc
  • Jenscare Scientific Co Ltd
  • Jiangsu Zhenyi Medical Technology Co Ltd
  • Lepu Medical Technology(Beijing)Co Ltd
  • LivaNova PLC
  • Medtronic Plc
  • Micro Interventional Devices, Inc.
  • MicroPort CardioFlow Medtech Corp
  • MicroPort Scientific Corp
  • MitrAssist Ltd.
  • MValve Technologies Ltd.
  • Neovasc Inc
  • NewMed Medical Co Ltd
  • P+F Products+Features GmbH
  • Polares Medical SA
  • Shanghai Shenqi Medical Technology Co Ltd
  • Sino Medical Sciences Technology Inc
  • Symetis SA
  • Tioga Medical Inc
  • Trinity College Dublin
  • University College London
  • Valcare Medical
  • Venus Medtech Hangzhou Inc

第6章 経カテーテル僧帽弁留置術(TMVI)- 最近の進歩

第7章 付録

  • 調査手法
  • GlobalDataについて
  • お問合せ
  • 免責事項
図表

List of Tables

  • Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
  • Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
  • Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
  • Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
  • Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
  • Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development
  • Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
  • Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
  • Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
  • Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
  • Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
目次
Product Code: GDME1724EPD

GlobalData's Medical Devices sector report, "Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Transcatheter Mitral Valve Implantation (TMVI) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Transcatheter Heart Valve is an artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium), all placed in a long narrow tube known as a catheter. The catheter is inserted into a large blood vessel in the groin area (transfemoral) or through a small incision in chest (transapical). Once inside the heart, the valve can then be opened into its natural position by inflation of a balloon and deployed within the patient's diseased mitral valve.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Transcatheter Mitral Valve Implantation (TMVI) Overview

3 Products under Development

  • 3.1 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
  • 3.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
  • 3.3 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
  • 3.4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
  • 3.5 Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials

4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products under Development by Companies

  • 4.1 Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development
  • 4.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development

5 Transcatheter Mitral Valve Implantation (TMVI) Companies and Product Overview

  • 5.1 4C Medical Technologies Inc Company Overview
    • 5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Abbott Vascular Inc Company Overview
    • 5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Annulon Company Overview
    • 5.3.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Cardiovalve Ltd Company Overview
    • 5.4.1 Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Cephea Valve Technologies, Inc. Company Overview
    • 5.5.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Colibri Heart Valve LLC Company Overview
    • 5.6.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Direct Flow Medical Inc (Inactive) Company Overview
    • 5.7.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Edwards Lifesciences Corp Company Overview
    • 5.8.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Emory University Company Overview
    • 5.9.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Foldax Inc Company Overview
    • 5.10.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Jenscare Scientific Co Ltd Company Overview
    • 5.11.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Jiangsu Zhenyi Medical Technology Co Ltd Company Overview
    • 5.12.1 Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Lepu Medical Technology (Beijing) Co Ltd Company Overview
    • 5.13.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 LivaNova PLC Company Overview
    • 5.14.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Medtronic Plc Company Overview
    • 5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Micro Interventional Devices, Inc. Company Overview
    • 5.16.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 MicroPort CardioFlow Medtech Corp Company Overview
    • 5.17.1 MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 MicroPort Scientific Corp Company Overview
    • 5.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 MitrAssist Ltd. Company Overview
    • 5.19.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 MValve Technologies Ltd. Company Overview
    • 5.20.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Neovasc Inc Company Overview
    • 5.21.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 NewMed Medical Co Ltd Company Overview
    • 5.22.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 P+F Products + Features GmbH Company Overview
    • 5.23.1 P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Polares Medical SA Company Overview
    • 5.24.1 Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 Shanghai Shenqi Medical Technology Co Ltd Company Overview
    • 5.25.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Sino Medical Sciences Technology Inc Company Overview
    • 5.26.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Symetis SA Company Overview
    • 5.27.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Tioga Medical Inc Company Overview
    • 5.28.1 Tioga Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Trinity College Dublin Company Overview
    • 5.29.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 University College London Company Overview
    • 5.30.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 Valcare Medical Company Overview
    • 5.31.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Venus Medtech Hangzhou Inc Company Overview
    • 5.32.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Transcatheter Mitral Valve Implantation (TMVI)- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer